BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 16102433)

  • 1. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
    Chang PP; Longenecker JC; Wang NY; Baughman KL; Conte JV; Hare JM; Kasper EK
    J Heart Lung Transplant; 2005 Aug; 24(8):998-1007. PubMed ID: 16102433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
    Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
    G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
    Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
    J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart transplantation 1985-1998: 13-years experience at Angelo De Gasperis Cardio-Thoracic Department-Milan.
    Colombo T; Vitali E; Lanfranconi M; Russo C; Bruschi G; Marchetti C; Colucci V; Frigerio M; Oliva F; Grassi M; Gronda E; Merli M; Pellegrini A
    Clin Transpl; 1998; ():315-25. PubMed ID: 10503110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heart transplantation 1985-1995: 10 years experience at the "Angelo De Gasperis" center. Improvement of results by progress in operative criteria].
    Colombo T; Borrello B; Lanfranconi M; Pomé G; Quaini E; Russo C; Vitali E; Grassi M; Frigerio M; Gronda E; Mangiavacchi M; Merli M; Pellegrini A
    G Ital Cardiol; 1997 Jan; 27(1):3-18. PubMed ID: 9244710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure.
    Delgado JF; Conde E; Sánchez V; López-Ríos F; Gómez-Sánchez MA; Escribano P; Sotelo T; Gómez de la Cámara A; Cortina J; de la Calzada CS
    Eur J Heart Fail; 2005 Oct; 7(6):1011-6. PubMed ID: 16227139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension.
    Toyoda Y; Thacker J; Santos R; Nguyen D; Bhama J; Bermudez C; Kormos R; Johnson B; Crespo M; Pilewski J; Teuteberg J; Alvarez R; Mathier M; McNamara D; McCurry K; Zenati M; Hattler B
    Ann Thorac Surg; 2008 Oct; 86(4):1116-22. PubMed ID: 18805144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study.
    Lee CK; Christensen LL; Magee JC; Ojo AO; Harmon WE; Bridges ND
    J Heart Lung Transplant; 2007 May; 26(5):458-65. PubMed ID: 17449414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
    Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
    J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
    Gorlitzer M; Ankersmit J; Fiegl N; Meinhart J; Lanzenberger M; Unal K; Dunkler D; Kilo J; Wolner E; Grimm M; Grabenwoeger M
    Transpl Int; 2005 Apr; 18(4):390-5. PubMed ID: 15773956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension and early mortality after orthotopic heart transplantation].
    López-Ciudad VJ; López Pérez JM; Fojón Polanco S; Blanco Sierra FJ; Pradas Montilla G; Cuenca Castillo JJ; Vázquez González N; Hermida Alvarez LF
    Rev Esp Cardiol; 1995 Aug; 48(8):552-6. PubMed ID: 7644809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
    Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
    J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
    J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.